Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Fuhrman Alan Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2023 4 Fuhrman Alan (Director) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Granted 5,150 shares @ $0
Granted 21,000 options to buy @ $1.37, valued at $28.8k
05/25/2023 4 Fuhrman Alan (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 4,648 shares @ $0
Granted 13,774 options to buy @ $32.27, valued at $444.5k
01/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
05/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Fuhrman Alan (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 4,818 shares @ $0
Granted 15,318 options to buy @ $35.42, valued at $542.6k
10/29/2021 4 Fuhrman Alan (See Remarks) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Granted 246,671 options to buy @ $3.93, valued at $969.4k
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 4 Fuhrman Alan (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 1,106 shares @ $0
Granted 6,998 options to buy @ $75.94, valued at $531.4k
08/06/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
05/29/2020 4 Fuhrman Alan (Director) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Granted 1,221 shares @ $0
05/22/2020 4 Fuhrman Alan (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 7,464 options to buy @ $38.03, valued at $283.9k
05/18/2020 4 Fuhrman Alan (Director) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Granted 11,003 shares @ $0
03/18/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
09/16/2019 4 Fuhrman Alan (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 29,983 options to buy @ $18, valued at $539.7k
09/12/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2018 4 Fuhrman Alan (Director) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 8,750 options to buy @ $180.98, valued at $1.6M
06/11/2018 4 Fuhrman Alan (Director) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 2,625 shares @ $178.0711, valued at $467.4k
Exercised 2,625 options to buy @ $11.35, valued at $29.8k
06/23/2017 4 Fuhrman Alan (Director) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 11,000 options to buy @ $78.58, valued at $864.4k
06/13/2016 4 Fuhrman Alan (Director) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 7,812 options to buy @ $24.18, valued at $188.9k
03/14/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
09/30/2015 4 Fuhrman Alan (CFO) has filed a Form 4 on Mirna Therapeutics, Inc.
Txns: Granted 167,180 options to buy @ $7, valued at $1.2M
07/30/2015 4 Fuhrman Alan (Director) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 7,812 options to buy @ $20.91, valued at $163.3k
01/14/2015 4 Fuhrman Alan (Director) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 15,625 options to buy @ $11.35, valued at $177.3k
11/12/2014 4 Fuhrman Alan (CFO) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns: Disposed/sold 6,309 shares @ $15, valued at $94.6k
Disposed/sold 100,277 options to buy @ $6, valued at $601.7k
Disposed/sold 68,369 options to buy @ $11.81, valued at $807.4k
Disposed/sold 45,000 options to buy @ $10.8, valued at $486k
Disposed/sold 27,517 restricted stock units @ $15, valued at $412.8k
05/19/2014 4 Fuhrman Alan (CFO) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns: Granted 27,517 restricted stock units @ $0
01/10/2014 4 Fuhrman Alan (CFO) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns: Granted 45,000 options to buy @ $10.8, valued at $486k
07/18/2013 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy